Controversial TOFT theory of cancer versus SMT model: Authors do battle in BioEssays
April 15, 2011 in CancerWriting in BioEssays, cancer scientists Ana Soto and Carlos Sonnenschein pit their controversial Tissue Organization Field Theory (TOFT) of the origin of cancer against the widely accepted Somatic Mutation Theory (SMT) in what is believed to be the first time the two theories have formally opposed each other championed by authors from opposite sides of the debate in a common forum for discussion.
Soto and Sonnenschein, from Tufts University, argue that SMT, which is based on the accumulation of genetic mutations in cells, not only fails to provide an explanation for observable phenomena in cancer biology, but with current technologies it is essentially untestable.
The TOFT theory proposes that cancer is a clonal, cell-based disease, and implicitly assumes that quiescence is the default state of cells in multicellular organisms.
"SMT is strongly supported by observations of leukemias that bear specific chromosome translocations," writes Dr David Vaux, from La Trobe Institute for Molecular Science, Australia, in defence of SMT. "Perhaps the strongest validation comes from the successful treatment of certain malignancies with drugs that directly target the product of the mutant gene."
"This appears to be the first time that the TOFT has formally gone head-to-head with the SMT in a common arena" said BioEssays, Editor-in-Chief Andrew Moore.
"BioEssays believes that science advances through the clear exposition of contrary views, and has created a new forum for vigorous debate which addresses the fundamental basis of cancer: may our readers decide for themselves!" adds David Thomas, BioEssays, Editorial Board Member, and co-editor of the Point<>Counterpoint pair.
More information: The abstracts are available free online here:
http://doi.wiley.c … es.201100022
http://doi.wiley.c … es.201100025
-
Endocrine-disrupting chemicals pose cancer risk
May 25, 2010 |
not rated yet |
0
-
Guardian of genome predicts treatment outcomes for childhood cancer
Nov 05, 2007 |
not rated yet |
0
-
Researchers find genetic link to leukemias with an unknown origin
Feb 18, 2010 |
not rated yet |
0
-
Video: Could cancer be our oldest ancestor?
Mar 31, 2011 |
not rated yet |
0
-
Cancer cells more likely to genetically mutate
Feb 19, 2007 |
not rated yet |
0
-
Seeing is as seeing does: Spatially-structured retinal input in early development of cortical maps
Apr 26, 2012 |
5 / 5 (3) |
1
-
Dreamless nights: Brain activity during nonrapid eye movement sleep
Apr 09, 2012 |
4.4 / 5 (12) |
0
-
Take your time: Neurobiology sheds light on the superiority of spaced vs. massed learning
Mar 28, 2012 |
4.5 / 5 (21) |
3
-
Your brain on 'shrooms: fMRI elucidates neural correlates of psilocybin psychedelic state
Feb 29, 2012 |
4.9 / 5 (41) |
45
-
Your brain on dye: Imaging neuronal voltage with fluorescent sensors and molecular wires
Feb 24, 2012 |
4.9 / 5 (9) |
0
-
Understanding the mechanisms of disease .
May 14, 2012
-
Short burst of hypersensitivity disorder?
May 13, 2012
-
Copper aspirinate
May 12, 2012
-
Ultraviolet rays and diseases
May 12, 2012
-
Article: Robot Reveals the Inner Workings of Brain Cells
May 11, 2012
-
Recommend to me the textbook on an inflammation, please
May 08, 2012
- More from Physics Forums - Medical Sciences
More news stories
Hormone-depleting drug shows promise against localized high-risk prostate tumors
A hormone-depleting drug approved last year for the treatment of metastatic prostate cancer can help eliminate or nearly eliminate tumors in many patients with aggressive cancers that have yet to spread beyond the prostate, ...
Cancer
5 hours ago |
5 / 5 (1) |
0
Experimental agent may help older people with chronic leukemia
The experimental drug ibrutinib (PCI-32765) shows great promise for the treatment of elderly patients with chronic lymphocytic leukemia (CLL), according to interim findings from a clinical trial.
Cancer
5 hours ago |
not rated yet |
0
Phase I study of temsirolimus, capecitabine proves safe; positive survival trend seen
A phase I clinical trial examining the safety of combining temsirolimus and capecitabine in advanced malignancies suggests the two agents can be given safely to patients. In addition, the Georgetown Lombardi Comprehensive ...
Cancer
5 hours ago |
5 / 5 (1) |
0
Revised glioblastoma classification should improve patient care
Radiation oncology researchers have revised the system used by doctors since the 1990s to determine the prognosis of people with glioblastoma, which is the most devastating of malignant brain tumors.
Cancer
5 hours ago |
not rated yet |
0
Study combines lapatinib with cetuximab to overcome resistance in EGFR-driven tumors
Targeted therapies have been studied for years, but recent laboratory research is providing robust clues about drugs that might work better in combination, particularly in treating cancers that have become resistant to therapy. ...
Cancer
5 hours ago |
not rated yet |
0
Paralyzed individuals control robotic arms to reach and grasp using brain computer interface (w/ Video)
In an ongoing clinical trial, a paralyzed woman was able to reach for and sip from a drink on her own for the first time in nearly 15 years by using her thoughts to direct a robotic arm. The ...
Zebrafish study isolates gene related to autism, schizophrenia and obesity
What can a fish tell us about human brain development? Researchers at Duke University Medical Center transplanted a set of human genes into a zebrafish and then used it to identify genes responsible for head ...
ApoE4 Alzheimer's gene causes brain's blood vessels to leak, die
Common variants of the ApoE gene are strongly associated with the risk of developing late-onset Alzheimer's disease, but the gene's role in the disease has been unclear. Now, researchers funded by the National ...
Landscape of cancer genes and mutational processes in breast cancer
In a study published today in Nature, researchers describe nine new genes that drive the development of breast cancer. This takes the tally of all genes associated with breast cancer development to 40.
Experts say psychiatry's diagnostic manual needs overhaul
The Diagnostic and Statistical Manual of Mental Disorders (DSM), long the master reference work in psychiatry, is seriously flawed and needs radical change from its current "field guide" form, according to an essay by two ...
Study finds common antibiotic azithromycin carries heart risk
Vanderbilt researchers have discovered a rare, but important risk posed by the antibiotic azithromycin, commonly called a "Z-pack." The study found a 2.5-fold higher risk of death from cardiovascular death in the first five ...